Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake
- PMID: 2657323
- DOI: 10.1016/0026-0495(89)90129-7
Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake
Abstract
The factors responsible for fasting hyperglycemia were investigated in 77 normal weight non-insulin-dependent diabetic (NIDD) and 72 age-, sex-, and weight-matched control individuals. In diabetic subjects with mild fasting hyperglycemia (less than 140 mg/dL) hepatic glucose production (1.85 +/- 0.03 mg/kg.min) was similar to controls (1.84 +/- 0.02); the major factor responsible for the elevated basal glucose level in the diabetic group was a decreased efficiency in the tissue uptake of glucose, as reflected by a 30% decline in the rate of glucose clearance (1.56 +/- 0.03 v 2.00 +/- 0.03 mL/kg.min, P less than .001). In contrast, in diabetic subjects with fasting plasma glucose concentrations above 140 mg/dL, basal hepatic glucose production was significantly elevated (2.42 +/- 0.08 mg/kg.min, P less than .001) and correlated closely with the increase in fasting plasma glucose concentration (r = .796, P less than .001). The basal rate of whole body glucose clearance reached a plateau value at fasting glucose levels of 160 to 180 mg/dL and did not contribute to the further rise in fasting plasma glucose concentrations above 160 to 180 mg/dL. Decreased efficiency of tissue glucose uptake is responsible the development of fasting hyperglycemia in patients with mild NIDDM (fasting plasma glucose less than 140 mg/dL). As the diabetic state worsens, an increase in basal hepatic glucose production is the major factor responsible for the progressive rise in fasting glucose levels.
Similar articles
-
Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose kinetics by short-term fasting.J Clin Endocrinol Metab. 1994 Mar;78(3):536-42. doi: 10.1210/jcem.78.3.8126123. J Clin Endocrinol Metab. 1994. PMID: 8126123
-
Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.J Clin Endocrinol Metab. 1991 Dec;73(6):1294-301. doi: 10.1210/jcem-73-6-1294. J Clin Endocrinol Metab. 1991. PMID: 1955512
-
Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.J Clin Invest. 1984 Mar;73(3):664-72. doi: 10.1172/JCI111258. J Clin Invest. 1984. PMID: 6368585 Free PMC article.
-
Mechanisms for hyperglycemia in type II diabetes mellitus: therapeutic implications for sulfonylurea treatment--an update.Am J Med. 1991 Jun 24;90(6A):8S-14S. doi: 10.1016/0002-9343(91)90412-q. Am J Med. 1991. PMID: 1872310 Review.
-
Islet dysfunction in non-insulin-dependent diabetes mellitus.Am J Med. 1988 Nov 28;85(5A):4-8. doi: 10.1016/0002-9343(88)90392-0. Am J Med. 1988. PMID: 3057894 Review.
Cited by
-
Attenuation of renovascular damage in Zucker diabetic fatty rat by NWT-03, an egg protein hydrolysate with ACE- and DPP4-inhibitory Activity.PLoS One. 2012;7(10):e46781. doi: 10.1371/journal.pone.0046781. Epub 2012 Oct 10. PLoS One. 2012. PMID: 23071636 Free PMC article.
-
Beta-cell dysfunction and glucose intolerance: results from the San Antonio metabolism (SAM) study.Diabetologia. 2004 Jan;47(1):31-9. doi: 10.1007/s00125-003-1263-9. Epub 2003 Dec 10. Diabetologia. 2004. PMID: 14666364
-
Roles of chlorogenic Acid on regulating glucose and lipids metabolism: a review.Evid Based Complement Alternat Med. 2013;2013:801457. doi: 10.1155/2013/801457. Epub 2013 Aug 25. Evid Based Complement Alternat Med. 2013. PMID: 24062792 Free PMC article. Review.
-
Surrogate measures of insulin sensitivity vs the hyperinsulinaemic-euglycaemic clamp: a meta-analysis.Diabetologia. 2014 Sep;57(9):1781-8. doi: 10.1007/s00125-014-3285-x. Epub 2014 Jun 3. Diabetologia. 2014. PMID: 24891021
-
Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study.Diabetes Care. 2013 Aug;36(8):2154-61. doi: 10.2337/dc12-2391. Epub 2013 Feb 14. Diabetes Care. 2013. PMID: 23412078 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials